Predict your next investment

Antios Therapeutics company logo
HEALTHCARE | Drug Development
antiostherapeutics.com

See what CB Insights has to offer

Total Raised

$125.4M

Investors Count

19

Antios Therapeutics Funding, Antios Therapeutics Valuation & Antios Therapeutics Revenue

3 Fundings

Antios Therapeutics's latest funding round was a Series B for $96M on April 12, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/12/2021

Series B

$96M

$0.00B

((9.99x))

FY 1234

3

8/17/2020

Unattributed VC

$99M

$0.00B

((9.99x))

FY 1234

10

11/27/2018

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/12/2021

8/17/2020

11/27/2018

Round

Series B

Unattributed VC

Series A

Amount

$96M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

3

10

10

Antios Therapeutics Investors

19 Investors

Antios Therapeutics has 19 investors. Domain Associates invested in Antios Therapeutics's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/27/2018

4/12/2021

3
Series A, Unattributed VC (2020), Series B (2021)

Venture Capital

New Jersey

11/27/2018

4/12/2021

2
Series A, Series B (2021)

Asset/Investment Management

New York

11/27/2018

4/12/2021

2
Series A, Series B (2021)

Venture Capital

Canada

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Hong Kong

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Private Equity

New York

First funding

11/27/2018

11/27/2018

11/27/2018

00/00/0000

00/00/0000

Last Funding

4/12/2021

4/12/2021

4/12/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

3
Series A, Unattributed VC (2020), Series B (2021)
2
Series A, Series B (2021)
2
Series A, Series B (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Venture Capital

Asset/Investment Management

Venture Capital

Venture Capital

Private Equity

Location

New Jersey

New York

Canada

Hong Kong

New York

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.